News for Twist Bioscience Corporation (TWST)

Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham.

[url="]Twist Bioscience Corporation[/url] (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today annou

Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space.

We recently published an article titled Billionaire Nicholas J.

We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against Nicholas J. Pritzker’s other stock picks with huge upside potential. Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, […]

Twist Bioscience and Ginkgo Bioworks revise their agreement, securing a $15M deal. Read more here.

Twist Bioscience's downbeat tone on the earnings call suggest there are challenges ahead. Read why it is difficult to argue TWST stock is meaningfully undervalued.

On May 6, 2025, leading financial services company Goldman Sachs made adjustments to its assessment of Twist Bioscience (TWST), reaffirming the "Buy" rating but

On May 6, 2025, Guggenheim analyst Subbu Nambi reaffirmed his positive outlook on Twist Bioscience (TWST), maintaining a "Buy" rating on the stock. The price ta

Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript May 5, 2025Twist Bioscience Corporation misses on earnings expectations.

Key Takeaways: Twist Bioscience has launched Atlas Data Storage with significant backing, demonstrating strategic growth initiatives. The company shows s

Discover Twist Bioscience's Q2 2025 earnings insights, including 23% revenue growth, gross margin gains, and strategic developments like the Atlas Data...

Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Conference Call April 5, 2025 8:00 AM ETCompany ParticipantsAngela Bitting - Senior Vice...

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today annou

Twist Bioscience (TWST) will release its fiscal 2025 Q2 financial results on May 5, 2025. A conference call and live webcast are scheduled for 8:00 AM Easte

Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics are part of the Zacks top Analyst Blog

**media[568943]**

Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.